Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region

Oncogene

Volumn 29, Issue 15, 2010, Pages 2302-2308

  Wu, S ^a,b   Huang, S ^b   Ding, J ^b   Zhao, Y ^b   Liang, L ^b   Liu, T ^b   Zhan, R ^a   He, X ^b  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

30 untranslated region; MiRNA; P21Cip1 Waf1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; MICRORNA;

3' UNTRANSLATED REGION; ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CHROMOSOME 19; GENE CLUSTER; HUMAN; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REPORTER GENE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 19; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION; GENES, REPORTER; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LUCIFERASES; MICRORNAS; MULTIGENE FAMILY; RNA, MESSENGER;

EID: 77951092028     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.34     Document Type: Article

References (23)

1. Abbas T, Dutta A. (2009). p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9: 400-414.
2. Ambros V. (2004). The functions of animal microRNAs. Nature 431: 350-355.
3. Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
4. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O et al. (2005). Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37: 766-770. (Pubitemid 41754896)
5. Bortolin-Cavaille ML, Dance M, Weber M, Cavaille J. (2009). C19MC microRNAs are processed from introns of large Pol-II, non-protein-coding transcripts. Nucleic Acids Res 37: 3464-3473.
6. Gartel AL, Tyner AL. (1999). Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res 246: 280-289.
7. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P et al. (2007). Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392. (Pubitemid 47362758)
8. Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG et al. (2009). CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothe-lioma-A miRNA microarray analysis. Genes Chromosomes Cancer 48: 615-623.
9. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816. (Pubitemid 23346377)
10. Hausser J, Berninger P, Rodak C, Jantscher Y, Wirth S, Zavolan M. (2009). MirZ: an integrated microRNA expression atlas and target prediction resource. Nucleic Acids Res 37: 266-W272.
11. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM et al. (2008). MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 28: 2167-2174. (Pubitemid 351429964)
12. Jongen-Lavrencic M, Sun SM, Dijkstra MK, Valk PJ, Lowenberg B. (2008). MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 111: 5078-5085.
13. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ et al. (2005). Combinatorial microRNA target predictions. Nat Genet 37: 495-500. (Pubitemid 40617277)
14. Lewis BP, Burge CB, Bartel DP. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
15. Lionetti M, Biasiolo M, Agnelli L, Todoerti K, Mosca L, Fabris S et al. (2009). Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma. Blood 114: e20-e26.
16. Lv K, Guo Y, Zhang Y, Wang K, Jia Y, Sun S. (2008). Allele-specific targeting of hsa-miR-657 to human IGF2R creates a potential mechanism underlying the association of ACAA-insertion/deletion polymorphism with type 2 diabetes. Biochem Biophys Res Commun 374: 101-105.
17. Martin-Caballero J, Flores JM, Garcia-Palencia P, Serrano M. (2001). Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. Cancer Res 61: 6234-6238.
18. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I et al. (2008). E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13: 272-286. (Pubitemid 351318375)
19. Topley GI, Okuyama R, Gonzales JG, Conti C, Dotto GP. (1999). p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. Proc Natl Acad Sci USA 96: 9089-9094. (Pubitemid 29374712)
20. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN. (2007). Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316: 575-579. (Pubitemid 46683138)
21. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R et al. (2006). A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124: 1169-1181.
22. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. (2008). Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 14: 2588-2592.
23. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. (1993). p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704. (Pubitemid 24036020)